$TLSA· SEC filing ·

TLSA Reports Positive Preclinical Data on Intranasal Anti-CD3 for Long COVID Brain Fog, Shows Neuroinflammation Reduction and Cognitive Improvement in Mouse Model, Co-Authored by Yale’s Iwasaki and Harvard’s Weiner, Study Published on bioRxiv, Highlights Potential for Non-Invasiv

Tiziana Life Sciences Ltd. Common Shares · Now $1.40

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS